IDEAYA Biosciences (IDYA) Revenue (2020 - 2026)

IDEAYA Biosciences has reported Revenue for 7 years, with the latest figure at $6.6 million in Q1 2026.

• Quarterly Revenue changed N/A year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $232.3 million (changed N/A YoY) and the FY2025 annual result came in at $218.7 million, up 3024.43% from the prior year.
• Revenue eased to $6.6 million in Q1 2026 per IDYA's latest filing, from $10.9 million in the prior quarter.
• Over five years, Revenue peaked at $207.8 million in Q3 2025 and troughed at $3.5 million in Q2 2023.
• A 5-year average of $25.5 million and a median of $7.4 million in 2023 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2023: Revenue surged 230.87% in 2022, then plunged 72.94% in 2023.
• Over 5 years, Revenue stood at $4.0 million in 2022, then fell by 2.49% to $3.9 million in 2023, then jumped by 78.48% to $7.0 million in 2024, then surged by 55.37% to $10.9 million in 2025, then slumped by 39.68% to $6.6 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $6.6 million, $10.9 million, and $207.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.